Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in active non-segmental vitiligo
2021-001442-35Phase 2Active
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pioglitazone in Vitiligo (2 arms), sponsored by Istituti Fisioterapici Ospitalieri. Primary endpoint: Vitiligo Area Scoring Index at Week 12. Started Jun 2021; status: active.
02
Drugs
pioglitazone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2021-001442-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001442-35.